Venture Challenge alumnus Cell4Phamra is excited to announce their involvement in the public-private consortium to develop a four organ on a chip model.
Organ-on-chip technology has allowed researchers to study physiological systems in vitro
Last week, the Venture Challenge Summer 2021 kicked off with innovative Life Sciences & Health startups participating in the first bootcamp. The participating teams worked on shaping their value propositions, vision and competitive differentiation to translate their idea into a solid business case.
UMC Utrecht carried out an investigator initiated large scale validation study for DeltaScan device performance, collecting data from a wide study population of 434 hospitalized patients, spread over 9 Dutch hospitals and 31 departments.
Dutch health ingredients innovator, NutriLeads, announces the appointment of Erik Dam as CEO to lead the company’s transition from a health ingredients innovator to a commercial health ingredients company based on a strong science foundation.
Are you a future BioBusiness leader in Life Sciences & Health? Register now for the TAP BioBusiness training programme and benefit from the early bird fee until 1 June 2021!
SeraNovo BV is pleased to announce the closing of a License Agreement with Graviton Bioscience Corporation (Graviton), a biopharmaceutical company engaged in the research and development of small molecules in the fields of oncology and neuroscience.
Crown Bioscience (CrownBio), a JSR Life Sciences company and leader in preclinical services that help biopharmaceutical companies accelerate new drug development programs, has acquired OcellO B.V., a privately owned contract research organization located in the Netherlands.